Thu, September 22, 2022

Keay Nakae Maintained (SONN) at Strong Buy on, Sep 22nd, 2022

Keay Nakae of Chardan Capital, Maintained "Sonnet BioTherapeutics Holdings, Inc." (SONN) at Strong Buy on, Sep 22nd, 2022.

Keay, nor any peers, have made any analyst calls on SONN in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30